Kaminari Medical
Developing a catheter that combines intravascular ultrasound and photoacoustic imaging in one catheter.
- horizon europe
- dt and ls
- spinout
- eit ecosystem
- surgery
- cardiology and cardiovascular
- eit health
- health it
- optical technology
- physician support tools
- medical imaging
- clinical decision support
- headstart (eit health)
- investor network (eit health)
- headstart 2019 (eit health)
- investor network 2019 (eit health)
- academic startup competition
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
* | €2.3m | Seed | |
| Total Funding | 000k | ||
Related Content
Kaminari Medical is an innovative startup focused on revolutionizing the diagnosis and treatment of coronary artery disease. The company combines ultrasound and optical imaging technologies to create advanced medical imaging solutions. This unique approach, known as photoacoustics, allows for the precise visualization of coronary artery plaques by detecting the sound waves generated when light impacts the plaque. This method aims to improve the accuracy and effectiveness of coronary revascularization procedures, which are treatments to restore blood flow to the heart.
Kaminari Medical primarily serves healthcare providers, including hospitals and cardiology clinics, that require advanced imaging solutions to diagnose and treat heart disease. The company operates in the medical technology market, which is a rapidly growing sector driven by the increasing prevalence of cardiovascular diseases and the demand for more accurate diagnostic tools.
The business model of Kaminari Medical is based on the development and commercialization of its proprietary imaging technology. The company generates revenue through the sale of its imaging devices and related software to healthcare institutions. Additionally, they may offer maintenance services, training, and support to ensure the effective use of their technology.
Kaminari Medical has gained recognition and support from various investors and organizations. For instance, the early-stage investor Uniiq has invested in the company, and it has been selected as a semi-finalist in the EIT Health Catapult 2021, a prestigious competition for health startups. Furthermore, the company received a grant from the MIT Haalbaarheid program to support its feasibility activities.
In summary, Kaminari Medical is at the forefront of medical imaging innovation, leveraging cutting-edge technology to enhance the diagnosis and treatment of coronary artery disease. The company is well-positioned in the medical technology market and continues to attract investment and recognition for its groundbreaking work.
Keywords: coronary artery disease, ultrasound, optical imaging, photoacoustics, medical technology, healthcare providers, diagnostic tools, revascularization, innovation, startup.